Veeva Systems Q4 FY1/24 Earnings Review

DISCLAIMER: This note is intended for US recipients only and, in particular, is not directed at, nor intended to be relied upon by any UK recipients. Any information or analysis in this note is not an offer to sell or the solicitation of an offer to buy any securities. Nothing in this note is intended to be investment advice and nor should it be relied upon to make investment decisions. Cestrian Capital Research, Inc., its employees, agents or affiliates, including the author of this note, or related persons, may have a position in any stocks, security, or financial instrument referenced in this note. Any opinions, analyses, or probabilities expressed in this note are those of the author as of the note's date of publication and are subject to change without notice. Companies referenced in this note or their employees or affiliates may be customers of Cestrian Capital Research, Inc. Cestrian Capital Research, Inc. values both its independence and transparency and does not believe that this presents a material potential conflict of interest or impacts the content of its research or publications.

Boring is not bad

By Abhishek Singh

Often, there are businesses that are talk of the town – everyone you know talks about them, and the media hypes them up. These are the securities that often elicit a FOMO response from retail investors, resulting in the purchase of the stock at unreasonable prices, only to see the stock plummet shortly after to the depths of mordor.

Then, there are stocks that may not frequently make headlines, but consistently deliver decent performance quarter after quarter, quietly solidifying their position in their industry. Veeva Systems is one such company - a leading provider of cloud solutions focused solely on the global life sciences industry. The company recently posted another decent quarter, with results surpassing guidance.

Company scored several wins in 2024, as summarized below: